<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://librepathology.org/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Lik</id>
	<title>Libre Pathology - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://librepathology.org/w/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Lik"/>
	<link rel="alternate" type="text/html" href="https://librepathology.org/wiki/Special:Contributions/Lik"/>
	<updated>2026-10-02T17:06:23Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.43.9</generator>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Cancer_staging_systems&amp;diff=35096</id>
		<title>Cancer staging systems</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Cancer_staging_systems&amp;diff=35096"/>
		<updated>2014-11-20T20:02:57Z</updated>

		<summary type="html">&lt;p&gt;Lik: /* Systems */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Image:Diagram showing the T stages of bladder cancer CRUK 372.svg|thumb|right|180px|Schematic showing the T stages in bladder cancer. (WC/CRUK)]]&lt;br /&gt;
&#039;&#039;&#039;Cancer staging systems&#039;&#039;&#039; are used to prognosticate cancer and determine treatment. They classify cancers based on the extent of tumour or the location of the tumour in relation to where it arose.&lt;br /&gt;
&lt;br /&gt;
=Overview=&lt;br /&gt;
===Systems===&lt;br /&gt;
*[[TNM staging system]] - most common, and used for the most common (adult) cancers.&lt;br /&gt;
*World Health Organization (WHO) grading system - for [[CNS tumours]].&lt;br /&gt;
*St. Jude system - pediatric pathology.&lt;br /&gt;
*Durie-Salmon system - for [[multiple myeloma]].&lt;br /&gt;
*Ann Arbour system - for [[Hodgkin lymphoma]] and non-Hodgkin lymphoma (excluding [[mycosis fungoides]] and Sezary syndrome).&lt;br /&gt;
*Sheldon system - for [[urachal carcinoma]].&amp;lt;ref name=pmid22901574&amp;gt;{{Cite journal  | last1 = Bruins | first1 = HM. | last2 = Visser | first2 = O. | last3 = Ploeg | first3 = M. | last4 = Hulsbergen-van de Kaa | first4 = CA. | last5 = Kiemeney | first5 = LA. | last6 = Witjes | first6 = JA. | title = The clinical epidemiology of urachal carcinoma: results of a large, population based study. | journal = J Urol | volume = 188 | issue = 4 | pages = 1102-7 | month = Oct | year = 2012 | doi = 10.1016/j.juro.2012.06.020 | PMID = 22901574 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Modified Masaoka Stage - for [[thymoma]]&lt;br /&gt;
&lt;br /&gt;
===Stage===&lt;br /&gt;
Most system are four tiered and use &#039;&#039;Roman numerals&#039;&#039; to denote the stage:&lt;br /&gt;
*Stage I: early cancer.&lt;br /&gt;
*Stage II: late early cancer (cancer between early and advanced stage).&lt;br /&gt;
*Stage III: advanced cancer - often defined by [[lymph node metastasis]].&lt;br /&gt;
*Stage IV: late advanced cancer - often defined by metastasis.&lt;br /&gt;
&lt;br /&gt;
==TNM staging system==&lt;br /&gt;
*Name of the system comes from the elements: &#039;&#039;&#039;T&#039;&#039;&#039;umour, &#039;&#039;&#039;N&#039;&#039;&#039;odes (lymph nodes), &#039;&#039;&#039;M&#039;&#039;&#039;etastasis (distant).&lt;br /&gt;
*Most common staging system.&lt;br /&gt;
*Staging parameters dependent on the specific site.&lt;br /&gt;
&lt;br /&gt;
===Modifiers===&lt;br /&gt;
Table of modifiers:&amp;lt;ref&amp;gt;URL: [http://www.cancer.gov/cancertopics/pdq/treatment/breast/healthprofessional/page3 http://www.cancer.gov/cancertopics/pdq/treatment/breast/healthprofessional/page3]. Accessed on: 28 March 2012.&amp;lt;/ref&amp;gt;&lt;br /&gt;
{| class=&amp;quot;wikitable sortable&amp;quot; style=&amp;quot;margin-left:auto;margin-right:auto&amp;quot; &lt;br /&gt;
! Modifier&lt;br /&gt;
! Meaning&lt;br /&gt;
! Example&lt;br /&gt;
! Notes&lt;br /&gt;
|-&lt;br /&gt;
| m&lt;br /&gt;
| multiple tumours&lt;br /&gt;
| pT(m)NM &#039;&#039;or&#039;&#039; pT2(2)N0Mx&lt;br /&gt;
| tumour stage = highest stage of all the individual tumours&lt;br /&gt;
|-&lt;br /&gt;
| c&lt;br /&gt;
| clinical stage&lt;br /&gt;
| cTNM&lt;br /&gt;
| if it is not specified &#039;&#039;clinical&#039;&#039; is assumed&lt;br /&gt;
|-&lt;br /&gt;
| p&lt;br /&gt;
| pathologic stage &lt;br /&gt;
| pTNM&lt;br /&gt;
| derived from a surgical specimen or biopsy&lt;br /&gt;
|-&lt;br /&gt;
| a&lt;br /&gt;
| stage at [[autopsy]]&lt;br /&gt;
| aTNM&lt;br /&gt;
| malignancy was &#039;&#039;&#039;not&#039;&#039;&#039; staged previously &#039;&#039;or&#039;&#039; treated - unless otherwise specified&lt;br /&gt;
|-&lt;br /&gt;
| y&lt;br /&gt;
| staging after therap&#039;&#039;&#039;y&#039;&#039;&#039;&lt;br /&gt;
| ypTNM&lt;br /&gt;
| do &#039;&#039;&#039;not&#039;&#039;&#039; try to estimate pretreatment stage&lt;br /&gt;
|-&lt;br /&gt;
| r&lt;br /&gt;
| recurrent tumour stage&lt;br /&gt;
| rTNM&lt;br /&gt;
| must have a clinically documented disease freedom&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
===Tumour stage===&lt;br /&gt;
Usually determined by one of the following:&lt;br /&gt;
#Size of the tumour (maximal dimension).&lt;br /&gt;
#Depth of invasion.&lt;br /&gt;
&lt;br /&gt;
Other factors:&lt;br /&gt;
*[[Lymphovascular invasion]] usually does not affect the tumour stage.&lt;br /&gt;
**Exceptions:&lt;br /&gt;
***[[Seminoma]].&lt;br /&gt;
***Intrahepatic bile duct carcinoma.&lt;br /&gt;
***[[Hepatocellular carcinoma]].&amp;lt;ref&amp;gt;URL: [http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/Hepatocellular_11protocol.pdf http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/Hepatocellular_11protocol.pdf]. Accessed on: 6 April 2012.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[Margin status]] usually does not affect the tumour stage.&lt;br /&gt;
**Exception:&lt;br /&gt;
***[[Prostate adenocarcinoma]] - bladder neck margin positivity.&lt;br /&gt;
&lt;br /&gt;
===Nodal stage===&lt;br /&gt;
*[[Lymph node]] involvement.&lt;br /&gt;
*Positive lymph nodes (without mets) often upstage to &#039;&#039;stage III&#039;&#039;.&lt;br /&gt;
**May upstage to &#039;&#039;stage II&#039;&#039; in some tumours.&lt;br /&gt;
*Sampling may be selective ([[sentinel lymph nodes]]).&lt;br /&gt;
&lt;br /&gt;
===Metastasis stage===&lt;br /&gt;
*[[Metastases]].&lt;br /&gt;
&lt;br /&gt;
=See also=&lt;br /&gt;
*[[Cancer]].&lt;br /&gt;
&lt;br /&gt;
=References=&lt;br /&gt;
{{Reflist|1}}&lt;br /&gt;
&lt;br /&gt;
=External links=&lt;br /&gt;
*[http://www.cancer.gov/cancertopics/factsheet/detection/staging Cancer staging (cancer.gov)] - an overview directed at individuals with cancer.&lt;br /&gt;
&lt;br /&gt;
[[Category:Basics]]&lt;/div&gt;</summary>
		<author><name>Lik</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Cancer_staging_systems&amp;diff=35095</id>
		<title>Cancer staging systems</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Cancer_staging_systems&amp;diff=35095"/>
		<updated>2014-11-20T20:02:29Z</updated>

		<summary type="html">&lt;p&gt;Lik: /* Overview */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Image:Diagram showing the T stages of bladder cancer CRUK 372.svg|thumb|right|180px|Schematic showing the T stages in bladder cancer. (WC/CRUK)]]&lt;br /&gt;
&#039;&#039;&#039;Cancer staging systems&#039;&#039;&#039; are used to prognosticate cancer and determine treatment. They classify cancers based on the extent of tumour or the location of the tumour in relation to where it arose.&lt;br /&gt;
&lt;br /&gt;
=Overview=&lt;br /&gt;
===Systems===&lt;br /&gt;
*[[TNM staging system]] - most common, and used for the most common (adult) cancers.&lt;br /&gt;
*World Health Organization (WHO) grading system - for [[CNS tumours]].&lt;br /&gt;
*St. Jude system - pediatric pathology.&lt;br /&gt;
*Durie-Salmon system - for [[multiple myeloma]].&lt;br /&gt;
*Ann Arbour system - for [[Hodgkin lymphoma]] and non-Hodgkin lymphoma (excluding [[mycosis fungoides]] and Sezary syndrome).&lt;br /&gt;
*Sheldon system - for [[urachal carcinoma]].&amp;lt;ref name=pmid22901574&amp;gt;{{Cite journal  | last1 = Bruins | first1 = HM. | last2 = Visser | first2 = O. | last3 = Ploeg | first3 = M. | last4 = Hulsbergen-van de Kaa | first4 = CA. | last5 = Kiemeney | first5 = LA. | last6 = Witjes | first6 = JA. | title = The clinical epidemiology of urachal carcinoma: results of a large, population based study. | journal = J Urol | volume = 188 | issue = 4 | pages = 1102-7 | month = Oct | year = 2012 | doi = 10.1016/j.juro.2012.06.020 | PMID = 22901574 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Modified Masaoka Stage - for [[thymomas]]&lt;br /&gt;
&lt;br /&gt;
===Stage===&lt;br /&gt;
Most system are four tiered and use &#039;&#039;Roman numerals&#039;&#039; to denote the stage:&lt;br /&gt;
*Stage I: early cancer.&lt;br /&gt;
*Stage II: late early cancer (cancer between early and advanced stage).&lt;br /&gt;
*Stage III: advanced cancer - often defined by [[lymph node metastasis]].&lt;br /&gt;
*Stage IV: late advanced cancer - often defined by metastasis.&lt;br /&gt;
&lt;br /&gt;
==TNM staging system==&lt;br /&gt;
*Name of the system comes from the elements: &#039;&#039;&#039;T&#039;&#039;&#039;umour, &#039;&#039;&#039;N&#039;&#039;&#039;odes (lymph nodes), &#039;&#039;&#039;M&#039;&#039;&#039;etastasis (distant).&lt;br /&gt;
*Most common staging system.&lt;br /&gt;
*Staging parameters dependent on the specific site.&lt;br /&gt;
&lt;br /&gt;
===Modifiers===&lt;br /&gt;
Table of modifiers:&amp;lt;ref&amp;gt;URL: [http://www.cancer.gov/cancertopics/pdq/treatment/breast/healthprofessional/page3 http://www.cancer.gov/cancertopics/pdq/treatment/breast/healthprofessional/page3]. Accessed on: 28 March 2012.&amp;lt;/ref&amp;gt;&lt;br /&gt;
{| class=&amp;quot;wikitable sortable&amp;quot; style=&amp;quot;margin-left:auto;margin-right:auto&amp;quot; &lt;br /&gt;
! Modifier&lt;br /&gt;
! Meaning&lt;br /&gt;
! Example&lt;br /&gt;
! Notes&lt;br /&gt;
|-&lt;br /&gt;
| m&lt;br /&gt;
| multiple tumours&lt;br /&gt;
| pT(m)NM &#039;&#039;or&#039;&#039; pT2(2)N0Mx&lt;br /&gt;
| tumour stage = highest stage of all the individual tumours&lt;br /&gt;
|-&lt;br /&gt;
| c&lt;br /&gt;
| clinical stage&lt;br /&gt;
| cTNM&lt;br /&gt;
| if it is not specified &#039;&#039;clinical&#039;&#039; is assumed&lt;br /&gt;
|-&lt;br /&gt;
| p&lt;br /&gt;
| pathologic stage &lt;br /&gt;
| pTNM&lt;br /&gt;
| derived from a surgical specimen or biopsy&lt;br /&gt;
|-&lt;br /&gt;
| a&lt;br /&gt;
| stage at [[autopsy]]&lt;br /&gt;
| aTNM&lt;br /&gt;
| malignancy was &#039;&#039;&#039;not&#039;&#039;&#039; staged previously &#039;&#039;or&#039;&#039; treated - unless otherwise specified&lt;br /&gt;
|-&lt;br /&gt;
| y&lt;br /&gt;
| staging after therap&#039;&#039;&#039;y&#039;&#039;&#039;&lt;br /&gt;
| ypTNM&lt;br /&gt;
| do &#039;&#039;&#039;not&#039;&#039;&#039; try to estimate pretreatment stage&lt;br /&gt;
|-&lt;br /&gt;
| r&lt;br /&gt;
| recurrent tumour stage&lt;br /&gt;
| rTNM&lt;br /&gt;
| must have a clinically documented disease freedom&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
===Tumour stage===&lt;br /&gt;
Usually determined by one of the following:&lt;br /&gt;
#Size of the tumour (maximal dimension).&lt;br /&gt;
#Depth of invasion.&lt;br /&gt;
&lt;br /&gt;
Other factors:&lt;br /&gt;
*[[Lymphovascular invasion]] usually does not affect the tumour stage.&lt;br /&gt;
**Exceptions:&lt;br /&gt;
***[[Seminoma]].&lt;br /&gt;
***Intrahepatic bile duct carcinoma.&lt;br /&gt;
***[[Hepatocellular carcinoma]].&amp;lt;ref&amp;gt;URL: [http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/Hepatocellular_11protocol.pdf http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2011/Hepatocellular_11protocol.pdf]. Accessed on: 6 April 2012.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[Margin status]] usually does not affect the tumour stage.&lt;br /&gt;
**Exception:&lt;br /&gt;
***[[Prostate adenocarcinoma]] - bladder neck margin positivity.&lt;br /&gt;
&lt;br /&gt;
===Nodal stage===&lt;br /&gt;
*[[Lymph node]] involvement.&lt;br /&gt;
*Positive lymph nodes (without mets) often upstage to &#039;&#039;stage III&#039;&#039;.&lt;br /&gt;
**May upstage to &#039;&#039;stage II&#039;&#039; in some tumours.&lt;br /&gt;
*Sampling may be selective ([[sentinel lymph nodes]]).&lt;br /&gt;
&lt;br /&gt;
===Metastasis stage===&lt;br /&gt;
*[[Metastases]].&lt;br /&gt;
&lt;br /&gt;
=See also=&lt;br /&gt;
*[[Cancer]].&lt;br /&gt;
&lt;br /&gt;
=References=&lt;br /&gt;
{{Reflist|1}}&lt;br /&gt;
&lt;br /&gt;
=External links=&lt;br /&gt;
*[http://www.cancer.gov/cancertopics/factsheet/detection/staging Cancer staging (cancer.gov)] - an overview directed at individuals with cancer.&lt;br /&gt;
&lt;br /&gt;
[[Category:Basics]]&lt;/div&gt;</summary>
		<author><name>Lik</name></author>
	</entry>
	<entry>
		<id>https://librepathology.org/w/index.php?title=Mediastinum&amp;diff=33613</id>
		<title>Mediastinum</title>
		<link rel="alternate" type="text/html" href="https://librepathology.org/w/index.php?title=Mediastinum&amp;diff=33613"/>
		<updated>2014-09-18T23:44:35Z</updated>

		<summary type="html">&lt;p&gt;Lik: /* Differenital diagnosis */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;The &#039;&#039;&#039;mediastinum&#039;&#039;&#039; is a place where tumours occasionally grow.  It is also a place one can find various cysts.&lt;br /&gt;
&lt;br /&gt;
=Differential diagnosis=&lt;br /&gt;
==General==&lt;br /&gt;
===Benign===&lt;br /&gt;
Common:&amp;lt;ref name=emed_med_cysts&amp;gt;URL: [http://emedicine.medscape.com/article/426659-overview#a0102 http://emedicine.medscape.com/article/426659-overview#a0102]. Accessed on: 15 November 2011.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[Bronchogenic cyst]].&lt;br /&gt;
*[[Enterogenous cyst]].&lt;br /&gt;
*[[Mesothelial cyst]].&lt;br /&gt;
*[[Neurenteric cyst]]. &amp;lt;!-- NOT &amp;quot;neuroenteric&amp;quot; --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Rare:&amp;lt;ref name=emed_med_cysts&amp;gt;URL: [http://emedicine.medscape.com/article/426659-overview#a0102 http://emedicine.medscape.com/article/426659-overview#a0102]. Accessed on: 15 November 2011.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*[[Thymic cyst]].&lt;br /&gt;
*[[Thoracic duct cyst]].&lt;br /&gt;
&lt;br /&gt;
===Malignant===&lt;br /&gt;
*[[Teratoma]] and other [[germ cell tumours]] (GCTs).&lt;br /&gt;
**[[Seminoma]]/[[dysgerminoma]] is the most common.&lt;br /&gt;
*Terrible [[lymphoma]].&lt;br /&gt;
*[[Thymoma]].&lt;br /&gt;
**Mix of epithelial cells and small lymphoid cells.&lt;br /&gt;
*[[Thyroid gland]].&lt;br /&gt;
*[[Metastasis]].&lt;br /&gt;
&lt;br /&gt;
===Rare===&lt;br /&gt;
*[[NUT midline carcinoma]].&lt;br /&gt;
&lt;br /&gt;
==Divided into subsites==&lt;br /&gt;
===Anterior===&lt;br /&gt;
*[[Thymoma]].&lt;br /&gt;
*[[Teratoma]] and other germ cell tumours.&lt;br /&gt;
*[[Thyroid gland]].&lt;br /&gt;
*Terrible [[lymphomas]].&lt;br /&gt;
&lt;br /&gt;
===Middle===&lt;br /&gt;
*[[Lymphoma]].&lt;br /&gt;
*Pericardial cyst.&lt;br /&gt;
*[[Bronchogenic cyst]].&lt;br /&gt;
&lt;br /&gt;
===Posterior===&lt;br /&gt;
*Neurogenic tumours.&lt;br /&gt;
*Gastroenteric cyst.&lt;br /&gt;
*[[GIST]].&lt;br /&gt;
&lt;br /&gt;
=Specific diagnoses=&lt;br /&gt;
==Fibrosing mediastinitis==&lt;br /&gt;
===General===&lt;br /&gt;
Clinical:&amp;lt;ref&amp;gt;{{Ref WMSP|143}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Fever.&lt;br /&gt;
*Cough.&lt;br /&gt;
&lt;br /&gt;
Etiology:&lt;br /&gt;
*Various - infectious, idiopathic.&amp;lt;ref name=pmid15988098&amp;gt;{{Cite journal  | last1 = Patil | first1 = PL. | last2 = Salkar | first2 = HR. | title = Idiopathic mediastinal fibrosis presenting as mediastinal compression syndrome. | journal = Indian J Med Sci | volume = 59 | issue = 6 | pages = 268-71 | month = Jun | year = 2005 | doi =  | PMID = 15988098 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Microscopic===&lt;br /&gt;
Features:&lt;br /&gt;
*Fibrous tissue.&lt;br /&gt;
*+/-Microorganisms.&lt;br /&gt;
&lt;br /&gt;
=See also=&lt;br /&gt;
*[[Lung]].&lt;br /&gt;
*[[Thymus]].&lt;br /&gt;
*[[Cytopathology]].&lt;br /&gt;
&lt;br /&gt;
=References=&lt;br /&gt;
{{Reflist|1}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Stuff]]&lt;/div&gt;</summary>
		<author><name>Lik</name></author>
	</entry>
</feed>